Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IV ipilimumab in melanoma
2013-002408-15Phase 4Completed
- Sponsor
- Oslo University Hospital
- Start
- Oct 2013
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ipilimumab in melanoma, eye melanoma and mucosal melanoma (MM), sponsored by Oslo University Hospital. Started Oct 2013; status: completed.
02
Drugs
ipilimumab
03
Conditions
melanomaeye melanomamucosal melanoma (MM)
Beyond the preview
Go deeper on 2013-002408-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002408-15.